Actively Recruiting
Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety
Led by Xiangya Hospital of Central South University · Updated on 2026-01-30
104
Participants Needed
1
Research Sites
70 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a randomized, multicenter, sham-controlled clinical trial designed to evaluate the efficacy and safety of acupuncture for patients with refractory rosacea. A total of 104 participants will be enrolled and randomly assigned in a 1:1 ratio to the acupuncture group or the sham acupuncture group (52 participants in each group, regardless of sex). The primary aim is to determine whether acupuncture can effectively alleviate facial erythema and flushing episodes compared with sham stimulation.
CONDITIONS
Official Title
Acupuncture for Refractory Rosacea: A Study on Its Effectiveness and Safety
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with refractory rosacea, unresponsive to at least 12 weeks of conventional oral medication, with persistent or recurrent symptoms affecting quality of life
- Age between 18 and 65 years, any sex
- Ability to understand the study and provide informed consent, willing to follow study procedures and follow-up
You will not qualify if you...
- Women who are pregnant, breastfeeding, or planning pregnancy soon
- Diabetes or moderate to severe systemic diseases affecting liver, kidney, lung, or blood systems
- Depression or other psychiatric disorders
- Severe abnormal reactions to acupuncture such as syncope or allergy
- Rosacea with nasal hypertrophy or other facial skin diseases or systemic disease skin symptoms
- Bleeding disorders or skin damage, infection, or lesions at acupuncture sites
- Recent discontinuation of antibiotics or other medications within specified timeframes
- Expected inability to comply with follow-up
- Participation in another clinical trial within 1 month before screening
- Any other condition deemed unsuitable by the investigator
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xiangya Hospital of Central South University
Changsha, Hunan, China, 410000
Actively Recruiting
Research Team
B
Ben Wang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here